Analysts Set Expectations for Elevance Health Q1 Earnings

Elevance Health, Inc. (NYSE:ELV) – Investment analysts at Zacks Research decreased their Q1 2025 earnings estimates for Elevance Health in a report issued on Thursday, January 30th. Zacks Research analyst K. Dey now forecasts that the company will post earnings of $10.40 per share for the quarter, down from their previous estimate of $10.76. The consensus estimate for Elevance Health’s current full-year earnings is $34.09 per share. Zacks Research also issued estimates for Elevance Health’s Q3 2025 earnings at $8.59 EPS and FY2027 earnings at $49.16 EPS.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%.

Several other equities analysts also recently weighed in on the company. StockNews.com downgraded Elevance Health from a “buy” rating to a “hold” rating in a research report on Monday, January 27th. Truist Financial cut their price objective on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Mizuho lowered their target price on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. Barclays upped their price target on shares of Elevance Health from $501.00 to $512.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $485.00 target price on shares of Elevance Health in a research report on Friday, January 24th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Elevance Health currently has an average rating of “Moderate Buy” and a consensus target price of $517.03.

Elevance Health Trading Down 0.9 %

Shares of NYSE ELV opened at $395.82 on Friday. Elevance Health has a 1-year low of $362.21 and a 1-year high of $567.26. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50. The business’s 50 day moving average is $386.63 and its two-hundred day moving average is $458.75. The stock has a market capitalization of $91.80 billion, a P/E ratio of 15.46, a PEG ratio of 1.20 and a beta of 0.84.

Institutional Investors Weigh In On Elevance Health

Large investors have recently modified their holdings of the business. Timber Creek Capital Management LLC boosted its stake in shares of Elevance Health by 17.7% during the fourth quarter. Timber Creek Capital Management LLC now owns 7,350 shares of the company’s stock valued at $2,711,000 after purchasing an additional 1,107 shares in the last quarter. Bank of Jackson Hole Trust bought a new stake in Elevance Health during the 4th quarter valued at $89,000. Valley Wealth Managers Inc. increased its holdings in shares of Elevance Health by 7.6% in the 4th quarter. Valley Wealth Managers Inc. now owns 40,349 shares of the company’s stock valued at $14,885,000 after acquiring an additional 2,846 shares during the period. CIBC Asset Management Inc raised its position in shares of Elevance Health by 20.4% in the 4th quarter. CIBC Asset Management Inc now owns 40,935 shares of the company’s stock worth $15,101,000 after acquiring an additional 6,923 shares in the last quarter. Finally, Evergreen Wealth Management LLC lifted its stake in shares of Elevance Health by 82.0% during the 4th quarter. Evergreen Wealth Management LLC now owns 9,741 shares of the company’s stock worth $3,593,000 after purchasing an additional 4,388 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be given a dividend of $1.71 per share. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.73%. Elevance Health’s dividend payout ratio is presently 25.46%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.